ISATUXIMAB Pharmacologic Class Indexing

Class set ID
31b8dc39-e1fa-4662-8713-9822deec6153
Version
1
Effective date
20210526
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | Genzyme Corporation | Sanofi Winthrop Industrie | Quality Assistance, S.A. | Lonza Biologics, Inc.2025061617